Issue

Issue: Collector's Edition 2007/2008

Findings just released at the 5th Annual International CoQ10 Symposium (November 9-12, 2007, in Kobe, Japan) show ubiquinol to be remarkably beneficial in those with advanced-stage cardiac disorders. Conventional CoQ10 (ubiquinone), on the other hand, was not adequately absorbed in these cardiac patients. According to the researchers, patients with severe heart failure have difficulty assimilating ubiquinone into their bloodstream, whereas ubiquinol readily absorbs and displays greater clinical benefit.

Reports

Departments

Recent Issues

Magazine Archives